Watch | Oxford's COVID-19 vaccine shows positive results

Oxford University & drugmaker AstraZeneca has developed an experimental coronavirus vaccine. This experimental vaccine shows a protective immune response in its early trials. According to researchers, it induced a strong antibody and T cell immune response.

The trials have also been expanded to other countries because of low levels of coronavirus in UK. Phase III trials will involve people from other countries like US, South Africa and Brazil. Many countries including Germany, France, Italy, & U.S. have already signed deals for the vaccine.

Our code of editorial values

Printable version | Sep 22, 2021 2:43:56 AM |

Next Story